The $500 Threshold Under Medicare

By Michael McCaughan / Email the Author / The RPM Report April 2006, Vol. 2, No. 4
CMS Beat / Word Count: 547 / Article # 2006500050

Executive Summary

The federal government is allowing Medicare prescription drug plans to make aggressive use of four-tier formularies. A key detail is the definition of products that qualify for the fourth "specialty" tier. CMS' rules will affect price negotiations for high cost drugs.

Purchase this Article

$35.00 Buy Now

For $35.00, purchase this 547-word article and receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: The $500 Threshold Under Medicare

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to The RPM Report will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel

The $500 Threshold Under Medicare

Executive Summary

Purchase this Article

Already a Subscriber?

Questions?

Related Articles: 5

Elsevier Business Intelligence Publications

Offers & Events

Topics Covered in this Article

Email Article